Significant Ownership of Peter Moll
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Peter Moll focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- PeterMoll - Owner
- Manager location
- Dresden, Germany
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Peter Moll with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Peter Moll
Significant Ownership of Peter Moll
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| HOWL | Werewolf Therapeutics, Inc. | Common stock 0,0001$ per share | 5.2% | $2,384,910 | 2,537,138 | MOLL PETER | 18 Sep 2026 |
Schedules 13D/G Reported by Peter Moll:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.